Sergej Konoplev, MD, PHD
Pathologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Morphological Assessment of Peripheral Blood, Bone Marrow, and Lymph Node Specimens
- Flow Cytometry Immunophenotypic Studies for Hematologic Malignancies
Request an Appointment
About Me
- Attending Pathologist
I competed my medical and postgraduate education in Saint Petersburg, Russia, where I served as an Attending Hematologist for five years while working on my PhD thesis in hematology. In contrast to the United States (U.S.), peripheral blood and bone marrow smears in Russia are reviewed by hematologists. There, I became fascinated by the specialty of hematopathology. As a clinician, I was also able to appreciate the importance of its role in the prompt and correct diagnosis of hematologic malignancies.
After defending my PhD thesis, I moved to the US, where I completed my training in pathology and hematopathology. In 2006, I joined the Department of Hematopathology at MD Anderson Cancer Center and worked there as an Attending Hematopathologist for 16 years. I reviewed peripheral blood smears and bone marrow, as well as lymph node and other tissue biopsy specimens with associated flow cytometry and immunohistochemistry studies.
Read more
My research focused on acute myeloid leukemia (AML) and B-lymphoblastic leukemia/lymphoma. I demonstrated the unique features of patients with de novo AML carrying the Philadelphia chromosome, which was subsequently recognized in the 2016 edition of World Health Organization classification. I also demonstrated that patients with terminal deoxynucleotidyl transferase (TdT)-positive aggressive B-cell lymphoma should be distinguished from patients with de novo B-lymphoblastic leukemia/lymphoma, which was subsequently recognized in the 2022 edition of World Health Organization classification.
While at MD Anderson, I also dedicated a significant amount of my time and efforts to the education of clinical fellows; for nine years, I directed the largest hematopathology fellowship program in the U.S. In 2023 I was honored to join the faculty of Memorial Sloan Kettering Cancer Center, where I continue my clinical, research, and educational efforts.
A pathologist is a doctor who uses a microscope to make a diagnosis from cell and tissue samples. They analyze the samples to learn the cause and effects of a health condition.
My Specialties
- Morphological Assessment of Peripheral Blood, Bone Marrow, and Lymph Node Specimens
- Flow Cytometry Immunophenotypic Studies for Hematologic Malignancies
Education
- MD, St. Petersburg State I.P. Pavlov Medical University
- PhD, Federal Institute of Hematology and Blood Transfusion
Residencies
- Internal Medicine, St. Petersburg State I.P. Pavlov Medical University
- Anatomic and Clinical Pathology, University of Cincinnati
- Anatomic and Clinical Pathology, The University of Texas Southwestern Medical Center
Fellowships
- Hematopathology, The University of Texas MD Anderson Cancer Center
- Advanced Hematopathology, The University of Texas MD Anderson Cancer Center
Board Certifications
- Anatomic and Clinical Pathology
- Hematopathology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Request an Opinion
Current Patients
Contact and Location
Dr. Konoplev sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Konoplev’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Sergej Konoplev discloses the following relationships and financial interests:
-
Cairo Diagnostics, LLC
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].